FDA asks LyphoMed to recall intravenous solution.
D004340:Drug Contamination; D004345:Drug Industry; D005069:Evaluation Studies as Topic; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration